0.812
cbdMD Inc stock is traded at $0.812, with a volume of 390.00K.
It is down -11.43% in the last 24 hours and down -6.58% over the past month.
See More
Previous Close:
$0.9168
Open:
$0.87
24h Volume:
390.00K
Relative Volume:
0.04
Market Cap:
$8.52M
Revenue:
$19.03M
Net Income/Loss:
$-1.51M
P/E Ratio:
-0.1311
EPS:
-6.1936
Net Cash Flow:
$-1.41M
1W Performance:
-11.41%
1M Performance:
-6.58%
6M Performance:
+11.23%
1Y Performance:
-74.48%
cbdMD Inc Stock (YCBD) Company Profile
Compare YCBD vs TAK, ZTS, HLN, TEVA, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
YCBD
cbdMD Inc
|
0.812 | 9.62M | 19.03M | -1.51M | -1.41M | -6.1936 |
|
TAK
Takeda Pharmaceutical Co Adr
|
18.44 | 59.23B | 29.85B | 776.90M | 4.35B | 0.2408 |
|
ZTS
Zoetis Inc
|
128.96 | 55.34B | 9.47B | 2.67B | 2.28B | 6.0218 |
|
HLN
Haleon Plc Adr
|
10.87 | 49.30B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
33.77 | 39.43B | 17.41B | 1.43B | 1.00B | 1.2182 |
|
UTHR
United Therapeutics Corp
|
513.82 | 21.70B | 3.13B | 1.27B | 1.12B | 26.39 |
cbdMD Inc Stock (YCBD) Latest News
How cyclical is cbdMD Inc.’s revenue streamJuly 2025 Retail & Fast Gain Stock Trading Tips - mfd.ru
Cbdmd Inc. Earnings Call Signals Cautious Recovery - The Globe and Mail
YCBD Stock Price, Forecast & Analysis | CBDMD INC (NYSEARCA:YCBD) - ChartMill
cbdMD, Inc. (AMEX:YCBD) Q1 2026 Earnings Call Transcript - Insider Monkey
cbdMD, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
cbdMD Inc (YCBD) Q1 2026 Earnings Call Highlights: Strategic Acquisitions and Financial ... By GuruFocus - Investing.com Canada
cbdMD reports narrowed Q1 net loss, issues going-concern warning - AlphaStreet News
cbdMD Reports Sequential Revenue Growth, Improved Liquidity, and Strong Start to Fiscal 2026 - Finviz
cbdMD Q1 Earnings Report: What Investors Need to Know - Benzinga
CbdMD Reports Sequential Revenue Growth, Improved Liquidity, and Strong Start to Fiscal 2026 - 富途牛牛
Earnings Outlook For cbdMD - Benzinga
cbdMD (YCBD) Q1 Earnings Preview: EPS and Revenue Expectations - GuruFocus
What are the future prospects of cbdMD Inc.July 2025 Trade Ideas & Real-Time Buy Signal Notifications - mfd.ru
Pullback Watch: Should I invest in cbdMD Inc before earningsJuly 2025 Retail & AI Enhanced Trading Signals - baoquankhu1.vn
Is cbdMD Inc. a top pick in the sector2025 Price Momentum & Accurate Trade Setup Notifications - mfd.ru
Will cbdMD Inc. benefit from government policyJuly 2025 Setups & Smart Swing Trading Alerts - mfd.ru
cbdMD, Inc. to Host Conference Call to Discuss December 31, 2025 First Quarter Results - Morningstar
Investors get Feb. 17 peek at cbdMD first-quarter results, 4:20 p.m. ET - Stock Titan
Earnings Beat: Is cbdMD Inc. stock a buy before product launchesTake Profit & Fast Exit Strategy with Risk Control - mfd.ru
Aug Highlights: Is cbdMD Inc a top pick in the sectorMarket Growth Report & Accurate Entry and Exit Point Alerts - baoquankhu1.vn
Is cbdMD Inc. stock showing strong momentumJuly 2025 Short Interest & Stepwise Trade Execution Plans - mfd.ru
Market Recap: Is cbdMD Inc in a bullish channel2025 Volume Leaders & Fast Momentum Stock Entry Tips - baoquankhu1.vn
cbdMD's Herbal Oasis Expands into Louisiana with Morales Beverage Group Following Strong Texas Momentum - Finviz
THC social seltzer Herbal Oasis moves into Louisiana alcohol-free aisles - Stock Titan
cbdMD Strengthens Regulatory Platform, Expanding Horizons - timothysykes.com
How High Will These Delta 9 Thc Gummies Get You Cbdmd Review - Geo News
cbdMD launches integrated regulatory science program after acquisition By Investing.com - Investing.com Nigeria
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
cbdMD launches integrated regulatory science program after acquisition - Investing.com
cbdMD Strengthens Regulatory Science Platform to Support Emerging Regulatory Cannabinoid Evaluation Pathways - Nasdaq
Valuation Update: How cyclical is cbdMD Inc.’s revenue streamWeekly Investment Recap & Safe Swing Trade Setup Alerts - mfd.ru
Aug Opening: Why is cbdMD Inc stock going downPortfolio Profit Report & Stepwise Trade Signal Implementation - baoquankhu1.vn
Is cbdMD Inc. stock forming a cup and handleInsider Selling & Smart Swing Trading Alerts - mfd.ru
Breakout Watch: What is the target price for Fortive Corporation stockQuarterly Risk Review & Advanced Swing Trade Entry Alerts - baoquankhu1.vn
Moving Averages: Is cbdMD Inc stock a buy or sellJuly 2025 Movers & Safe Entry Momentum Stock Tips - baoquankhu1.vn
Aug Intraday: Can cbdMD Inc be the next market leaderEarnings Miss & Accurate Intraday Trading Signals - baoquankhu1.vn
Earnings Recap: Will cbdMD Inc outperform tech stocksJuly 2025 Market Mood & AI Powered Buy and Sell Recommendations - baoquankhu1.vn
Retail Trends: Why is Prestige Consumer Healthcare Inc stock going up2025 Key Highlights & High Conviction Trade Alerts - baoquankhu1.vn
Whale Trades: Can cbdMD Inc be the next market leader2025 Top Decliners & High Accuracy Investment Entry Signals - baoquankhu1.vn
cbdMD Announces Strategic Acquisition of Bluebird Botanicals - Sahm
cbdMD acquires hemp brand Bluebird Botanicals in all-equity deal By Investing.com - Investing.com Nigeria
Wall Street Recap: Will TSVT stock recover after earningsWeekly Loss Report & AI Enhanced Market Trend Forecasts - baoquankhu1.vn
cbdMD acquires Gaia Botanicals assets in stock-based transaction By Investing.com - Investing.com Nigeria
cbdMD announces strategic acquisition of Bluebird Botanicals - marketscreener.com
cbdMD acquires hemp brand Bluebird Botanicals in all-equity deal - Investing.com
cbdMD Acquires Bluebird Botanicals - mg Magazine
cbdMD acquires Gaia Botanicals assets in stock-based transaction - Investing.com
cbdMD Expands Portfolio with Bluebird Botanicals Acquisition - TipRanks
cbdMD Signs Asset Purchase Agreement With Bluebird Botanicals - TradingView
cbdMD Acquires Bluebird Botanicals Assets, Strengthening Revenue Base - Intellectia AI
MSN Money - MSN
cbdMD Inc Stock (YCBD) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):